Intervention Core - Improving Provider Announcement Communication Training (IMPACT)

抽象--干预核心 干预核心将支持拟议的计划项目，“改善提供商公告” 传播培训(IMPACT)“，目的是改善卫生保健系统中的HPV疫苗接种。这个 干预核心将综合关于以下项目实施和有效性的具体项目调查结果 常规订单支持(项目1)、财政激励(项目2)和临床冠军(项目3)进入 公告方法培训(AAT)干预一揽子计划。AAT是一个简短的沟通研讨会， 帮助初级保健团队改进他们推荐HPV疫苗的方式，并解决父母的担忧。在一个 在之前的随机临床试验中，AAT使HPV疫苗覆盖率比对照增加了5个百分点 短短3个月内。拟议的计划项目寻求通过将AAT与 将在项目1-3中测试的干预措施。然后，计划项目将比较人口影响和 这些干预措施的成本效益，包括在农村地区(项目4)。干预核心将支持 P01中的四个研究项目旨在最大限度地提高AAT干预措施的质量和可比性 并在5年的研究期内进行评估。目标1是召集临床咨询委员会，以提供 具有多学科实施支持的项目。我们的董事会包括儿科、家庭领域的领导者 医学、护理、质量改进，以及患者和家人的倡导。通过每季度召开一次会议， 董事会将支持制定干预材料，招募和保留临床地点，以及 研究结果的解释和传播。目标2是准备AAT辅导员和培训 干预投递材料。为了实现最高质量的干预，我们将集中(1) 培训将向初级保健团队提供AAT讲习班的促进者，以及(2)准备 干预材料。目标3是协调对包括费用在内的执行措施的评估。 干预核心将监测在项目1-3中收集的执行数据的质量，以确保 及时性、完整性和准确性。这项质量监测将支持成功完成 项目4‘S的成本-效果分析等资料，用于AAT干预一揽子计划。目标4是 促进在全国范围内传播研究结果和干预材料。与 项目1-4，干预核心将向学术界、临床界的受众传播研究成果 实践，和公共卫生。最值得注意的是，核心将领导AAT干预的产生 用于改善医疗系统中的HPV疫苗接种的一揽子计划。总而言之，干预核心将是 有助于计划项目改善初级保健团队的沟通，增加HPV的目标 疫苗接种，并确保当今的年轻人对未来的HPV具有最高水平的保护 癌症。干预核心通过建设HPV的能力来解决影响方案项目的主题 医疗保健系统中初级保健团队之间的疫苗交流干预。

ABSTRACT – Intervention Core The Intervention Core will support the proposed Program Project, “Improving Provider Announcement Communication Training (IMPACT)” with the goal of improving HPV vaccination in healthcare systems. The Intervention Core will synthesize project-specific findings regarding the implementation and effectiveness of standing orders support (Project 1), financial incentives (Project 2), and clinical champions (Project 3) into the Announcement Approach Training (AAT) Intervention Package. AAT is a brief communication workshop that helps primary care teams improve the way they recommend HPV vaccine and address parents' concerns. In a prior randomized clinical trial, AAT increased HPV vaccine coverage by 5 percentage points over the control within just 3 months. The proposed Program Project seeks to amplify AAT's impact by combining it with the interventions to be tested in Projects 1-3. The Program Project will then compare the population impact and cost-effectiveness of these interventions, including in rural areas (Project 4). The Intervention Core will support the four research projects in the P01 to maximize the quality and comparability of AAT interventions delivered and evaluated over the 5-year study period. Aim 1 is to convene a Clinical Advisory Board to provide projects with multi-disciplinary implementation support. Our board includes leaders in pediatrics, family medicine, nursing, quality improvement, and patient and family advocacy. Through quarterly meetings, the board will support the development of intervention materials, the recruitment and retention of clinical sites, and the interpretation and dissemination of study findings. Aim 2 is to prepare AAT facilitators and training materials for intervention delivery. To achieve the highest-quality interventions, we will centralize (1) the training of the facilitators who will deliver our AAT workshops to primary care teams and (2) the preparation of intervention materials. Aim 3 is to harmonize assessment of implementation measures, including cost. The Intervention Core will monitor the quality of implementation data collected in Projects 1-3 to ensure timeliness, completeness, and accuracy. This quality monitoring will support the successful completion of Project 4's cost-effectiveness analyses and other information for the AAT Intervention Package. Aim 4 is to facilitate the national dissemination of study findings and intervention materials. Collaborating with Projects 1-4, the Intervention Core will disseminate study deliverables to audiences in academia, clinical practice, and public health. Most notably, the Core will lead the production of the AAT Intervention Package for improving HPV vaccination in healthcare systems. In sum, the Intervention Core will be instrumental to the Program Project's goals of improving primary care teams' communication, increasing HPV vaccine uptake, and ensuring that today's youth have the highest level of protection against future HPV cancers. The Intervention Core addresses the IMPACT Program Project theme by building capacity for HPV vaccine communication interventions among primary care teams in healthcare systems.